References 1 Zhou M et al . Mortality , morbidity , and risk factors in China and its provinces , 1990-2017 : a systematic analysis for the Global Burden of Disease Study 2017 . Lancet 2019 ; 394 ( 10204 ): 1145 – 58 . 2 International Agency for Research on Cancer . The Global Cancer Observatory ( GCO ) Platform . https :// gco . iarc . fr / today / ( accessed July 2021 ). 3 Zeng H et al . Cancer survival in China , 2003 – 2005 : a populationbased study . Int J Cancer 2015 ; 36 ( 8 ): 1921 – 30 . 4 Zhou J et al . Guidelines for the diagnosis and treatment of hepatocellular carcinoma ( 2019 edn ). Liver Cancer 2020 ; 9 ( 6 ): 682 – 720 . 5 Zhu Q et al . Hepatocellular carcinoma in a large medical center of China over a 10-year period : evolving therapeutic option and improving survival . Oncotarget 2015 ; 6 ( 6 ): 4440 – 50 . 6 Bureau of Medical Administration , National Health Commission of the People ’ s Republic of China . Guidelines for diagnosis and treatment of primary liver cancer in China ( 2019 Edition ). Chin J Practical Surg 2020 ; 40 ( 2 ): 121 – 38 . 7 Tzartzeva K et al . Surveillance imaging and alpha fetoprotein for early detection of |
hepatocellular carcinoma in patients with cirrhosis : A meta-analysis . Gastroenterology 2018 ; 154 ( 6 ): 1706 – 18 . 8 Parikh ND et al . Costeffectiveness of hepatocellular carcinoma surveillance : An assessment of benefits and harms . Am J Gastroenterol 2020 ; 115 ( 10 ): 1642 – 9 . 9 Hepatobiliary & Pancreatic Diseases Prevention and Control Section , Chinese Preventive Medicine Association , Chinese Research Hospital Association , Chinese Society of Hepatology , etc . Guideline for stratified screening and surveillance of primary liver cancer ( 2020 edn ). Chin J Cancer Prevent Treat 2021 ; 28 ( 2 ): 83 – 99 . 10 Wang Z et al . Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection : A randomized controlled study . Clin Cancer Res 2018 ; 24 ( 9 ): 2074 – 81 . 11 CSCO . Guidelines of the Chinese Society of Clinical Oncology : Hepatocellular carcinoma . 2020 . 12 Bruix J et al . Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation ( STORM ): a phase 3 , randomised , double-blind , placebo-controlled trial . Lancet Oncol 2015 ; 16 ( 13 ): 1344 – 54 . |
13 Jianyong L et al . Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma : a single center analysis . Ann Hepatol 2014 ; 13 ( 4 ): 394 – 402 . 14 Sasaki A et al . Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma . Eur J Surg Oncol 2006 ; 32 ( 7 ): 773 – 9 . 15 Qi X et al . Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma : A systematic review and meta-analysis . Oncotarget 2015 ; 6 ( 34 ): 36838 – 59 . 16 Ogasawara S et al . P-107 LEAP-012 : A randomized , double-blind , phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization ( TACE ) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatment . Ann Oncol 2020 ; 31 ( Supplement 3 ): S123 – S125 . 17 Wu Z et al . 1018TiP ALTER-H-004 : A phase II study of anlotinib combined with TACE as adjuvant therapy in hepatocellular carcinoma |
patients at high risk of postsurgery recurrence . Ann Oncol 2020 ; 31 ( Supplement 4 ): S703 . 18 Polito C , Martin GS . Albumin : physiologic and clinical effects on lung function . Minerva Anestesiol 2013 ; 79 ( 10 ): 1180 – 6 . 19 Rungsakulkij N et al . Preoperative serum albumin is associated with intra-abdominal infection following major hepatectomy . J Hepatobiliary Pancreat Sci 2019 ; 26 ( 11 ): 479 – 89 . 20 Shen J et al . The prognostic prediction role of preoperative serum albumin level in patients with intrahepatic cholangiocarcinoma following hepatectomy . Dig Dis 2018 ; 36 ( 4 ): 306 – 13 . 21 Jeong HW et al . Early postoperative hypoalbuminaemia is associated with pleural effusion after donor hepatectomy : A propensity score analysis of 2316 donors . Sci Rep 2019 ; 9 ( 1 ): 2790 . 22 Sang BH et al . Hypoalbuminemia within two postoperative days is an independent risk factor for acute kidney injury following living donor liver transplantation : A propensity score analysis of 998 consecutive patients . Crit Care Med 2015 ; 43 ( 12 ): 2552 – 61 . 23 Ertmer C et al . Impact of human albumin infusion on organ function in orthotopic liver |
transplantation--a retrospective matched-pair analysis . Clin Transplant 2015 ; 29 ( 1 ): 67 – 75 . 24 Group of Liver Surgery , Chinese Surgical Society , Chinese Medical Association . Expert consensus on perioperative management of hepatectomy . Chin J Practical Surg 2017 ; 37 ( 5 ): 525 – 30 . 25 Group of Liver Surgery , Chinese Surgical Society , Chinese Medical Association . Chinese Expert Consensus on Enhanced Recovery after Hepatectomy ( 2017 Edition ). Chin J Hepat Surg ( Electronic Edition ) 2017 ; 6 ( 4 ): 254 – 60 . 26 Benson AB et al . Guidelines Insights : Hepatobiliary cancers , Version 2.2019 . J Natl Compr Canc Netw 2019 ; 17 ( 4 ): 302 – 10 . 27 Hepatocellular Carcinoma MDT Team of West China Hospital , Sichuan University . Multidisciplinary standard full-course management of hepatocellular carcinoma : Multidisciplinary expert consensus of West China Hospital , Sichuan University ( 2nd edn ). Chin J Bases Clinics General Surg 2020 ; 27 ( 9 ): 1062 – 77 . |